ABL

Abbott Laboratories · TRADEGATE:ABL

96.94 EUR1.80 +1.89%

Abbott Laboratories (TRADEGATE:ABL) last traded at 96.94 EUR, up 1.89% on the day. Over the past year the stock is down 9.97%. Its 52-week range is 69.62 to 113.84. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open94.98

Day range94.20 – 97.44

52-week range69.62 – 113.84

Volume2.61 K

Average volume (10 days)1.90 K

Market cap (USD)183.77 B

P/E40.54

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)0.3618

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+4.48%1 week

+13.01%1 month

+3.72%3 months

+29.81%6 months

−9.06%Year to date

−9.97%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.